There’s Still Time to Buy Editas Medicine Inc (NASDAQ:EDIT) Stock

In Friday’s Wall Street session, Editas Medicine Inc (NASDAQ:EDIT) shares traded at $1.92, down -6.80% from the previous session. EDIT stock price is now 33.53% away from the 50-day moving average and -44.70% away from the 200-day moving average. The market capitalization of the company currently stands at $158.49M. In other news, O’Neill Gilmore Neil, […]

Before You Invest In Editas Medicine Inc (NASDAQ:EDIT), Consider This Metric

Stocks of Editas Medicine Inc (NASDAQ:EDIT) traded higher last session on Wall Street, up 12.20% to $1.38. EDIT stock price is now -2.81% away from the 50-day moving average and -60.99% away from the 200-day moving average. The market capitalization of the company currently stands at $113.92M. , while ‘Stifel’ rates the stock as ‘Hold’ […]

Fosters Research
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.